Previous Article | Next Article ![]()
Journal of Virology, January 2000, p. 755-763, Vol. 74, No. 2
Molecular Neuro-Oncology Laboratory,
Massachusetts General Hospital, Charlestown, Massachusetts 02129, and Harvard Medical School, Boston, Massachusetts 02115
Received 17 June 1999/Accepted 8 October 1999
Progressive multifocal leukoencephalopathy (PML) is a fatal
demyelinating disease that results from an oligodendrocyte infection caused by JC virus. The JC virus early promoter directs cell-specific expression of the viral replication factor large T antigen, and thus
transcriptional regulation constitutes a major mechanism of glial
tropism in PML. We have previously demonstrated that T antigen controls
the JC virus basal promoter in a glial cell-specific manner, since T
antigen repressed the JC virus and simian virus 40 (SV40) early
promoters in glioma cells but induced strong activation of the JC virus
early promoter in nonglial cells. To further analyze these findings, T
antigen and nuclear extracts from glial and nonglial cells were used to
examine DNase I footprints on the proximal promoter. T-antigen binding
to site II was more extensive than expected based on sequence homology
with SV40, and nuclear proteins protected several regions of the
proximal promoter in a cell-specific manner. Multiple Sp1 binding
domains were identified. Site-directed mutagenesis revealed that
T-antigen-mediated activation required a TATA box sequence, a
pentanucleotide repeat immediately upstream of the TATA box, and
an Sp1 binding site downstream of the TATA box. When footprints were
obtained with mutant promoters which blocked T-antigen-induced
transactivation, no change in T-antigen binding was observed. These
results suggest that T antigen activates the JC virus basal promoter in
nonglial cells by interaction with the transcription
initiation complex.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Glial Cell-Specific Regulation of the JC Virus
Early Promoter by Large T Antigen
*
Corresponding author. Mailing address: Molecular
Neuro-Oncology Laboratory, Massachusetts General Hospital, 149 13th
St., Charlestown, MA 02129. Phone: (617) 726-5510. Fax: (617)
726-5079. E-mail: henson{at}helix.mgh.harvard.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|